Research and Development

Showing 15 posts of 9607 posts found.

Professor Trevor Jones CBE appointed chairman of Simbec Research

July 24, 2013 Manufacturing and Production, Research and Development, Sales and Marketing ABPI, simbec, trevor jones

Clinical research organisation Simbec Research has appointed Professor Trevor Jones CBE as non-executive chairman of the Board of directors. Jones …
ros_bilton_strategic_north

Strategic North hires Rosalyn Bilton as consultant

July 23, 2013 Medical Communications, Research and Development, Sales and Marketing Strategic North, bilton

Healthcare agency Strategic North has welcomed its latest recruit Rosalyn Bilton to the team in the role of consultant. Bilton …
Zelboraf image

Eight in ten survive skin cancer

July 22, 2013 Research and Development, Sales and Marketing Yervoy, Zelboraf, melanoma, skin cancer

The vast majority of men and women diagnosed with malignant melanoma are now surviving the disease, according to a new …

ReNeuron relocates to Wales

July 22, 2013 Research and Development, Sales and Marketing ReNeuron, Wales, stem cell, stroke

The Welsh government is to fork out a £7.8 million grant package to get English stem cell research company ReNeuron …
alexander_triebnigg_panpharma

Panpharma appoints Novartis senior head

July 22, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, celesio AG, panpharma

Pharma trading group Celesio AG has announced that Alexander Triebnigg has taken over the management of the Brazilian pharma wholesaler …
EFPIA image

Secret EFPIA memo on data transparency leaked

July 22, 2013 Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, EMA, PhRMA, transparency

A memo from the European pharma lobby group EFPIA has revealed that the industry is trying to ‘mobilise’ patient groups …

ASCO: Dispatches from the frontline against cancer

July 22, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, McConaghie

The growing promise of pharma’s immunotherapy pipeline for cancer was undoubtedly the hottest topic at this year’s ASCO conference. The …
Lucentis image

Lucentis and Avastin equal in efficacy

July 19, 2013 Research and Development, Sales and Marketing Lucentis, Novartis, Roche, avastin

Latest results released this morning from a UK government trial show that off-label use of Roche’s Avastin is just as …

Funding boost for lung cancer ‘map’

July 18, 2013 Research and Development, Sales and Marketing cancer research, lung cancer, tracerx

A new Cancer Research UK study aims to unlock lung cancer’s secrets by tracking how lung tumours develop and evolve …
steven_couldwell_tissue_regenix

Tissue Regenix appoints Sanofi VP

July 18, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing couldwell, tissue regenix

Medical devices firm Tissue Regenix has appointed Steven Couldwell as a non-executive director. With over 14 years of senior management …
lundbeck image

Lundbeck/Otsuka Alzheimer’s drug improves cognition

July 17, 2013 Research and Development, Sales and Marketing Alzheimer's, Lundbeck, Otsuka

Lundbeck and partner Otsuka have posted positive Phase II results for their experimental Alzheimer’s drug. The latest data show statistically …
winchpharma_lyndon_ceo

WinchPharma appoints new chief executive

July 17, 2013 Manufacturing and Production, Research and Development, Sales and Marketing lyndon nicholson, winchpharma

Healthcare products firm WinchPharma has appointed Lyndon Nicholson as its new chief executive with immediate effect.  Nicholson will replace former …
Brain scan image

Dementia rates declining in UK

July 17, 2013 Research and Development, Sales and Marketing Alzheimer's, UK, brain, dementia

A new study has found that the rate of dementia in Britain has decreased over the past two decades, contrary …
syntaxin image

Ipsen buys Syntaxin

July 16, 2013 Research and Development, Sales and Marketing R&D, ipsen, neurology, syntaxin, tsi

French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …

Roche ‘considers’ Alexion bid

July 16, 2013 Research and Development, Sales and Marketing Alexion, Orphan, Roche, soliris

Speculation that Roche is considering a bid for rare disease specialist Alexion Pharmaceuticals has unleashed a flurry of comment – …
The Gateway to Local Adoption Series

Latest content